LEXX Competitors & Alternatives

Compare Lexaria Bioscience Corp with similar stocks in the same industry

Biotechnology

LEXX

Main Stock
$4.41
-0.68%
Tradestie Score
32
Market Cap
$21.68M
Revenue Growth
-88.5%
Analyst Upside
+1770.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: DehydraTECH
Major Customers 3
pharmaceutical licensees cannabis product manufacturers nicotine delivery companies
Critical Suppliers 2
API manufacturers contract research organizations
Direct Ecosystem Rivals 1

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SRZN Surrozen, Inc. Common
$32.32
+2.25%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$27.12
-8.19%
$110.20M - 32 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.02
-2.89%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.48
-4.59%
$67.94M - 52 Compare
KTTA Pasithea Therapeutics Corp. Common Stock
$0.50
-4.21%
$5.73M - 38 Compare
INM InMed Pharmaceuticals Inc. Common Shares
$15.56
+17.79%
$5.29M - 35 Compare
PRFX PainReform Ltd. Ordinary Shares
$0.69
-11.22%
$2.78M - 36 Compare
NMAD NMAD
$2.80
+19.15%
- - 44 Compare
VRPX VRPX
- - - - Compare
none major public tickers none major public tickers
- - - - Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

219 stocks in this industry